At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...

US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59: London, UK Saturday, April 19, 2025, 09:00 Hrs [IST] GSK ...

The U.S. is experiencing an outbreak of measles and is on track to have the most whooping cough cases since 1948; these ...

The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.

Current public health guidelines only recommend an early third MMR dose for infants traveling internationally.

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.

China is not as big a player in the manufacturing of key ingredients used to make brand and generic medicines as previously ...

The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.

On April 4, 2025, the Centers for Medicare & Medicaid Services (“CMS”) released the contract year (“CY”) 2026 final rule for the Medicare ...

The US has 800 confirmed cases of measles, a 12% increase from the week prior in an outbreak that has reached nearly half the ...